Bicocca Open Archive

Logo unimib boa
BOMBELLI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.289
AS - Asia 9.849
EU - Europa 7.163
SA - Sud America 1.434
AF - Africa 246
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 15
Totale 34.012
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.922
SG - Singapore 3.928
CN - Cina 2.043
IT - Italia 1.301
HK - Hong Kong 1.293
RU - Federazione Russa 1.237
DE - Germania 1.184
VN - Vietnam 1.147
BR - Brasile 1.056
SE - Svezia 859
IE - Irlanda 714
UA - Ucraina 452
GB - Regno Unito 398
FR - Francia 319
IN - India 301
CA - Canada 237
FI - Finlandia 201
KR - Corea 167
BD - Bangladesh 160
AR - Argentina 142
TR - Turchia 106
IQ - Iraq 104
ID - Indonesia 102
ZA - Sudafrica 85
NL - Olanda 83
ES - Italia 77
MX - Messico 76
PK - Pakistan 69
PL - Polonia 68
EC - Ecuador 60
AT - Austria 58
JP - Giappone 58
CO - Colombia 56
PH - Filippine 52
SA - Arabia Saudita 51
DK - Danimarca 49
UZ - Uzbekistan 48
VE - Venezuela 36
CL - Cile 32
MA - Marocco 27
EG - Egitto 25
CZ - Repubblica Ceca 24
KE - Kenya 24
BE - Belgio 20
AZ - Azerbaigian 19
IR - Iran 18
JO - Giordania 18
MY - Malesia 18
PY - Paraguay 18
RO - Romania 18
AE - Emirati Arabi Uniti 16
PE - Perù 16
LB - Libano 15
TN - Tunisia 15
AU - Australia 14
ET - Etiopia 14
AL - Albania 13
LT - Lituania 13
TH - Thailandia 13
TW - Taiwan 12
CH - Svizzera 11
DZ - Algeria 11
EU - Europa 11
JM - Giamaica 11
UY - Uruguay 11
IL - Israele 10
KZ - Kazakistan 10
OM - Oman 10
PA - Panama 10
BG - Bulgaria 9
NP - Nepal 9
BH - Bahrain 8
DO - Repubblica Dominicana 8
PT - Portogallo 8
TT - Trinidad e Tobago 8
PS - Palestinian Territory 7
SN - Senegal 7
BO - Bolivia 6
GR - Grecia 6
HN - Honduras 6
HU - Ungheria 6
KH - Cambogia 6
LK - Sri Lanka 6
LV - Lettonia 6
BY - Bielorussia 5
CI - Costa d'Avorio 5
EE - Estonia 5
SY - Repubblica araba siriana 5
BB - Barbados 4
GE - Georgia 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BJ - Benin 3
GT - Guatemala 3
LA - Repubblica Popolare Democratica del Laos 3
LY - Libia 3
QA - Qatar 3
XK - ???statistics.table.value.countryCode.XK??? 3
BF - Burkina Faso 2
Totale 33.961
Salva come PNG Salva come JPEG
Città #
Singapore 2.084
Ann Arbor 1.953
Ashburn 1.432
Hong Kong 1.283
San Jose 1.116
Woodbridge 944
Fairfield 824
Houston 782
Frankfurt am Main 732
Chandler 708
Dublin 674
Wilmington 490
Jacksonville 466
New York 451
Dearborn 435
Milan 389
Seattle 378
Beijing 358
Santa Clara 345
Ho Chi Minh City 316
Hanoi 295
Hefei 294
Chicago 280
Cambridge 268
Princeton 244
Dallas 241
Los Angeles 234
The Dalles 164
Seoul 158
Lauterbourg 138
Nanjing 130
Moscow 126
Shanghai 123
Altamura 122
Lawrence 117
Buffalo 100
São Paulo 93
Munich 90
Lachine 80
San Diego 77
Helsinki 76
Orem 74
Council Bluffs 62
Guangzhou 62
Da Nang 55
London 52
Nanchang 52
Haiphong 51
Jakarta 50
Baghdad 49
Warsaw 49
Rome 48
Toronto 48
Boardman 46
Andover 43
Tokyo 42
Tashkent 40
Chennai 38
Dong Ket 38
Fremont 38
Johannesburg 38
Tianjin 38
Brooklyn 37
Montreal 37
Rio de Janeiro 37
Hebei 36
Nuremberg 34
Shenyang 34
Salt Lake City 33
Vienna 33
Denver 31
Falls Church 31
Lissone 31
Atlanta 29
Turku 29
Changsha 27
Manchester 27
Amsterdam 26
Dhaka 26
Phoenix 26
Monza 25
Mumbai 24
Ottawa 24
Stockholm 24
Jiaxing 22
Kunming 22
New Delhi 22
Poplar 22
Jinan 21
Ningbo 21
Quito 21
Belo Horizonte 20
Columbus 20
Nürnberg 20
Zhengzhou 20
Porto Alegre 19
Brno 18
Buenos Aires 18
Nairobi 18
Norwalk 18
Totale 21.606
Salva come PNG Salva come JPEG
Nome #
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 460
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 401
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage 350
Differing associations for sport versus occupational physical activity and cardiovascular risk 349
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 342
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 321
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 318
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 318
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 310
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 308
The Pamela study: main findings and perspectives 298
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 292
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 289
Vitamin B12 deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report 287
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 287
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 286
HYPERTENSIVE EMERGENCIES AND URGENCIES: ADHERENCE TO GUIDELIENS AND RELATIONSHIP BETWEEN BLOOD PRESSURE MANAGEMENT AND IN-HOSPITAL MORTALITY 282
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 282
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 280
Prevalence and clinical significance of a greater ambulatory versus office blood pressure ('reversed white coat' condition) in a general population 278
Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study) 275
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 272
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 266
Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events 265
Accuracy evaluation of the 'Cardiette BP one' ambulatory blood pressure monitor 265
Combined effects of hypertension and hypercholesterolemia on radial artery function 265
Neuroadrenergic disarray in pseudo-resistant and resistant hypertension 262
Impact of demographic, anthropometric, haemodynamic factors on left atrial size in the general population: data from the PAMELA study 261
New-onset left atrial enlargement in a general population 261
Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study 260
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 259
Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension 257
Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure 255
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 255
Role of ambulatory blood pressure monitoring in resistant hypertension 254
The association between 24-h blood pressure patterns and left ventricular mechanics 253
Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population 252
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 251
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 250
Blood pressure variability and organ damage in a general population: Results from the PAMELA study 249
Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population 249
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study 249
IMPORTANCE OF URIC ACID THRESHOLD IN ITS CORRELATION WITH METABOLIC SYNDROME 246
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 246
Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population 245
Comparison of the new alpha 1-blocker alfuzosin with propranolol as first-line therapy in hypertension 243
C68 RESTING HEART RATE AND ARTERIAL STIFFNESS: A LONGITUDINAL PROSPECTIVE STUDY IN A POPULATION OF HYPERTENSIVE PATIENTS 242
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients 242
Diurnal blood pressure variation and sympathetic activity 239
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 239
Simultaneous validation of the SunTech 247 diagnostic station blood pressure measurement device according to the British hypertension society protocol, the international protocol and the association for the advancement of medical instrumentation standards 238
Blood pressure (clinic, home, 24-h) profiles and clinical correlates in 236
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 234
Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: The PAMELA Study 233
Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: Data from the PAMELA study 230
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 230
HIV and metabolic syndrome - A comparison with the general population 229
Should white-coat hypertension in diabetes be treated? Pro 229
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population 229
Importance of uric acid threshold in its correlation with metabolic syndrome 229
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 228
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 228
Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data from the PAMELA Study 228
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 226
The Pamela Study: Old and New Findings 224
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: The PAMELA study 224
Prognostic value of "partial" and "true" white coat hypertension: data from 16 year follow-up in the PAMELA population 223
Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage 222
Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (Urrah Project) 221
The PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) study: Main features and results 221
Neurological hypertensive emergencies: Correlation of blood pressure values with in-hospital outcomes in ischemic stroke 220
Predictive value of different indices of blood pressure variability on 220
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 220
Resting Heart Rate and Arterial Stiffness: a Longitudinal Prospective Study in a Population of Hypertensive Patients 219
Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population 218
Metabolic Syndrome is Related to Vascular Structural Alterations But Not to Functional one both in Hypertensives and Healthy Subjects in Selected abstracts from the XXXVIII National Congress of the Italian Society of Hypertension (SIIA) 215
Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy 214
Long-term risk of sustained hypertension in white-coat or masked hypertension 212
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 212
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 212
Incidence and risk factors for delayed intracranial hemorrhage after mild brain injury in anticoagulated patients: a multicenter retrospective study 211
Long-term prognistic value of white-coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements 210
Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation? 208
Diagnosis and management of patients with white-coat and masked hypertension 204
Long-term increase in serum uric acid and its predictors over a 25 year follow-up: Results of the PAMELA study 203
Aortic root diameter and risk of cardiovascular events in a general population: data from the PAMELA study 203
Metabolic syndrome is related to vascular structural alterations but not to functional ones both in hypertensives and healthy subjects 203
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 202
4C.07:Relationships between cognitive dysfunction, clinic and ambulatory blood pressure and blood pressure variability: results from the PAMELA Study 202
Aortic root diameter and risk of cardiovascular events in a general population: the PAMELA study 199
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population: The PAMELA study 199
Williams syndrome is associated with an increase in heart rate and wave reflection values during the nighttime period. 199
Association between ADRA1A gene and the metabolic syndrome: Candidate genes and functional counterpart in the PAMELA population 198
Bloodstream infections due to multi-drug resistant bacteria in the emergency department: prevalence, risk factors and outcomes—a retrospective observational study 197
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 197
Do reverse dippers have the highest risk of right ventricular remodeling? 196
Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis 193
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study 192
Ambulatory blood pressure in air traffic controllers 190
Nighttime Blood Pressure and New-Onset Left Ventricular Hypertrophy: Findings From the Pamela Population 187
Totale 24.682
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.033
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021579 0 0 0 0 0 0 0 0 0 262 114 203
2021/20221.706 109 159 172 182 148 144 63 76 104 114 129 306
2022/20233.123 312 901 277 258 214 468 53 207 183 56 114 80
2023/20242.396 62 71 104 123 298 598 457 91 232 43 35 282
2024/20256.152 319 718 285 281 476 170 269 274 570 858 737 1.195
2025/202612.263 1.463 858 1.083 1.505 1.539 703 2.148 605 1.130 1.229 0 0
Totale 34.658